Condyloma and coincidental epidermodysplasia verruciformis acanthoma positive for human papillomavirus-14 and -21
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
Epidermodysplasia verruciformis (EDV) is a rare genodermatosis that predisposes individuals to persistent infection with β-human papillomavirus (HPV) genotypes. The term EDV acanthoma may be applied to lesions with incidental findings of EDV-defining histopathological features without clinical signs of EDV. We report a case of HPV-14- and -21-positive EDV acanthoma arising in association with condyloma in a female patient with a history of low-grade squamous intraepithelial lesion of the cervix positive for high-risk HPV (non-16/18), chronic kidney disease, and systemic lupus erythematosus. The patient had no family or personal history of EDV, but the patient was on immunosuppressive therapy with mycophenolate mofetil and prednisone. A biopsy specimen from one of the perianal lesions revealed histopathologic changes consistent with EDV in the setting of condyloma. Molecular testing showed HPV-14 and -21, which supported the coexistence of condyloma with EDV acanthoma.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
---|---|
Enthalten in: |
Journal of cutaneous pathology - 50(2023), 1 vom: 01. Jan., Seite 47-50 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bartley, Brooke [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acanthoma |
---|
Anmerkungen: |
Date Completed 02.01.2023 Date Revised 03.01.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/cup.14319 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345570820 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345570820 | ||
003 | DE-627 | ||
005 | 20231226025347.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/cup.14319 |2 doi | |
028 | 5 | 2 | |a pubmed24n1151.xml |
035 | |a (DE-627)NLM345570820 | ||
035 | |a (NLM)36039682 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bartley, Brooke |e verfasserin |4 aut | |
245 | 1 | 0 | |a Condyloma and coincidental epidermodysplasia verruciformis acanthoma positive for human papillomavirus-14 and -21 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.01.2023 | ||
500 | |a Date Revised 03.01.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
520 | |a Epidermodysplasia verruciformis (EDV) is a rare genodermatosis that predisposes individuals to persistent infection with β-human papillomavirus (HPV) genotypes. The term EDV acanthoma may be applied to lesions with incidental findings of EDV-defining histopathological features without clinical signs of EDV. We report a case of HPV-14- and -21-positive EDV acanthoma arising in association with condyloma in a female patient with a history of low-grade squamous intraepithelial lesion of the cervix positive for high-risk HPV (non-16/18), chronic kidney disease, and systemic lupus erythematosus. The patient had no family or personal history of EDV, but the patient was on immunosuppressive therapy with mycophenolate mofetil and prednisone. A biopsy specimen from one of the perianal lesions revealed histopathologic changes consistent with EDV in the setting of condyloma. Molecular testing showed HPV-14 and -21, which supported the coexistence of condyloma with EDV acanthoma | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a acanthoma | |
650 | 4 | |a condyloma | |
650 | 4 | |a epidermodysplasia verruciformis | |
650 | 4 | |a human papillomavirus-14 and -21 | |
650 | 4 | |a immunocompromised host | |
650 | 4 | |a squamous cell carcinoma | |
700 | 1 | |a Cho, Woo Cheal |e verfasserin |4 aut | |
700 | 1 | |a Rady, Peter L |e verfasserin |4 aut | |
700 | 1 | |a Dai, Julia |e verfasserin |4 aut | |
700 | 1 | |a Curry, Jonathan L |e verfasserin |4 aut | |
700 | 1 | |a Milbourne, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Tyring, Stephen K |e verfasserin |4 aut | |
700 | 1 | |a Torres-Cabala, Carlos A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of cutaneous pathology |d 1974 |g 50(2023), 1 vom: 01. Jan., Seite 47-50 |w (DE-627)NLM000403180 |x 1600-0560 |7 nnns |
773 | 1 | 8 | |g volume:50 |g year:2023 |g number:1 |g day:01 |g month:01 |g pages:47-50 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/cup.14319 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 50 |j 2023 |e 1 |b 01 |c 01 |h 47-50 |